Medicare Enrolled

Dr. Michael Lipinski, MD, PHD

Cardiovascular Disease · Fort Myers, FL
Practice pattern: Cardiac & Electrophysiology— Practice combining cardiac and electrophysiology services
Speaking/Promotional
13340 METRO PKWY STE 200, Fort Myers, FL 33966
2393430550
In practice since 2007 (18 years)
NPI: 1184846289 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lipinski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lipinski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lipinski

Dr. Michael Lipinski is a cardiovascular disease in Fort Myers, FL, with 18 years in practice. Based on federal Medicare data, Dr. Lipinski performed 4,172 Medicare services across 3,097 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lipinski received a total of $243,922 from 8 pharmaceutical and/or device companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lipinski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 27% volume in FL$ $243,922 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,172
Medicare services
Top 27% in FL for cardiovascular disease
3,097
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~232 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)914$87$200
Electrocardiogram (EKG), 12-lead754$10$79
Echocardiogram, transthoracic400$137$947
Regadenoson injection (Lexiscan) for heart stress test273$32$43
Technetium tc-99m sestamibi, diagnostic, per study dose223$59$75
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes198$10$154
Cardiac catheterization135$186$1,219
EKG interpretation and report120$6$35
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician118$48$369
Office visit, established patient (20-29 min)114$57$135
Nuclear medicine studies of heart muscle at rest and with stress and spect110$332$1,403
Coronary stent placement89$366$1,268
Heart rhythm recording of continous external ekg over 8-15 days68$9$123
Hospital follow-up visit, high complexity64$93$198
Heart rhythm review and interpretation of continous external ekg over 8-15 days49$18$112
New patient office visit (45-59 min)48$113$309
Hospital follow-up visit, moderate complexity45$61$138
Ultrasound of heart blood flow, valves and chambers, follow-up44$19$120
Initial hospital admission, moderate complexity38$102$258
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician37$16$96
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician37$11$64
Initial hospital admission, high complexity37$136$381
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report36$166$971
Ultrasound of heart blood flow, valves and chambers28$40$267
Insertion of tube in coronary artery for diagnosis with review by radiologist28$143$999
Ultrasound of heart with color-depicted blood flow, rate and valve function26$19$158
Injection, octafluoropropane microspheres, per ml23$28$110
Hospital discharge day management, 30 minutes or less21$63$136
Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel20$47$219
Office visit, established patient, complex (40-54 min)20$137$270
Ultrasound of heart, follow-up16$63$413
Electrocardiogram (ecg) 2-day continuous with review by health care professional14$9$112
Electrocardiogram (ecg) 2-day continuous13$10$123
Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist12$239$1,373
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.6% high complexity
16.1% medium
66.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$243,922
Total received (2018-2024)
Avg $34,846/year across 7 years
Top 2% in FL for cardiovascular disease
8
Companies
124
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$243,536 (99.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$387 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$46,678
2023
$30,339
2022
$26,705
2021
$14,264
2020
$14,993
2019
$74,676
2018
$36,268

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$243,536
Kiniksa Pharmaceuticals, Ltd.
$105
Boston Scientific Corporation
$74
Novartis Pharmaceuticals Corporation
$69
Amgen Inc.
$60
Cardiovascular Systems Inc.
$34
E.R. Squibb & Sons, L.L.C.
$23
Abbott Laboratories
$20
Top 3 companies account for 99.9% of total payments
Associated products mentioned in payments ›
Arcalyst · CERDELGA · CEREZYME · Diamondback Peripheral · ELIQUIS · ENTRESTO · FABRAZYME · FABRY-DISEASE · FlexAbility Ablation Catheter · INGEVITY+ · LUMIZYME · Repatha · WATCHMAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (100%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for cardiovascular disease in FL.

Equivalent to $5,847 per 100 Medicare services performed
Looking for a cardiovascular disease in Fort Myers?
Compare cardiovascular diseases in the Fort Myers area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
84
Per 100K population
10.6
County median income
$73,099
Nearest hospital
GULF COAST MEDICAL CENTER LEE HEALTH
3.3 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Lipinski is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 27% in FL), and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Lipinski experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lipinski performed 914 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lipinski receive payments from pharmaceutical companies?
Yes. Dr. Lipinski received a total of $243,922 from 8 companies across 124 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lipinski's costs compare to other cardiovascular diseases in Fort Myers?
Dr. Lipinski's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lipinski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →